当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 资产负债表

华北制药

(600812)

  

流通市值:80.47亿  总市值:80.47亿
流通股本:17.16亿   总股本:17.16亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金1,179,654,647.041,384,871,890.281,541,414,202.121,605,062,335.69
  应收票据及应收账款2,549,737,177.862,604,085,233.42,411,368,822.432,422,540,197.37
        应收账款2,549,737,177.862,604,085,233.42,411,368,822.432,422,540,197.37
  应收款项融资265,583,560.89259,054,539.81183,670,124.47350,394,389.11
  预付款项114,979,068.98107,247,114.9393,989,453.56207,259,110.33
  其他应收款合计1,272,819,718.341,395,477,329.931,382,129,629.941,407,547,938.6
  其中:应收利息-175,000175,000-
  存货2,472,074,763.152,413,363,684.092,410,852,410.362,253,265,923.69
  其他流动资产123,381,451.76101,250,614.78107,871,454.590,550,497.32
  流动资产合计7,978,230,388.028,265,350,407.228,131,296,097.388,336,620,392.11
非流动资产:
  长期股权投资1,277,486,915.131,261,742,427.131,247,085,553.171,228,642,491.57
  其他权益工具投资5,035,0005,035,0005,035,00017,700,000
  固定资产6,144,216,650.076,223,254,1286,362,233,837.346,256,511,256.9
  在建工程321,900,162.62269,048,271.09259,600,989.02378,116,789.56
  使用权资产169,128,876.77248,024,031.25257,803,948.97331,771,339.51
  无形资产3,032,218,488.62,987,910,610.223,024,497,212.092,846,843,592.12
  开发支出2,073,635,144.332,073,185,197.611,986,986,026.042,009,743,438.68
  长期待摊费用75,119,266.0967,571,620.8468,214,510.2258,901,559.49
  递延所得税资产51,652,922.9850,889,164.7449,150,212.7372,434,064.62
  非流动资产合计13,150,393,426.5913,186,660,450.8813,260,607,289.5813,200,664,532.45
  资产总计21,128,623,814.6121,452,010,858.121,391,903,386.9621,537,284,924.56
流动负债:
  短期借款5,736,841,515.286,366,431,515.286,242,124,372.076,619,707,942.87
  应付票据及应付账款2,527,083,117.772,429,543,702.572,451,020,041.532,198,867,569.75
  其中:应付票据497,002,217.98448,512,698.42476,610,979.31391,107,979.2
        应付账款2,030,080,899.791,981,031,004.151,974,409,062.221,807,759,590.55
  合同负债133,067,022.13164,984,118.37161,481,735.16167,621,266.19
  应付职工薪酬189,440,038.79189,619,334.02183,604,195.52194,880,533.46
  应交税费44,134,044.0563,324,823.160,266,659.3555,729,751.74
  其他应付款合计307,813,669.42308,268,168.92310,697,076.33468,003,915.97
  其中:应付利息641,854.492,170,999.66771,055.8611,151,367.37
        应付股利385,687.5385,687.5385,687.5385,687.5
  一年内到期的非流动负债1,548,754,074.181,894,024,627.912,971,999,114.52,185,396,153.03
  其他流动负债12,697,163.5720,470,238.7918,071,190.23519,466,289.37
  流动负债合计10,499,830,645.1911,436,666,528.9612,399,264,384.6912,409,673,422.38
非流动负债:
  长期借款3,048,858,0002,351,818,0001,376,674,659.722,181,118,000
  应付债券500,000,000500,000,000500,000,000-
  租赁负债104,458,874.49124,529,982.74124,434,082.95149,772,417.7
  长期应付款16,180,00016,180,00016,180,0008,317,000
  递延收益90,783,187.1688,373,585.8289,802,253.5785,271,762.15
  递延所得税负债551,027.44551,027.44551,027.4429,103,732.43
  非流动负债合计3,760,831,089.093,081,452,5962,107,642,023.682,453,582,912.28
  负债合计14,260,661,734.2814,518,119,124.9614,506,906,408.3714,863,256,334.66
所有者权益(或股东权益):
  实收资本(或股本)1,715,730,3701,715,730,3701,715,730,3701,715,730,370
  资本公积3,869,826,456.163,869,810,132.553,869,792,329.163,869,803,463.59
  其他综合收益-9,221,598.65-7,974,360.77-6,312,061.397,725,829.76
  专项储备3,442,189.961,969,228.75806,861.41,703,679.8
  盈余公积339,420,156.84339,420,156.84339,420,156.84333,357,636.58
  未分配利润-400,811,036.21-369,133,555.76-404,606,383.25-423,096,005.08
  归属于母公司股东权益合计5,518,386,538.15,549,821,971.615,514,831,272.765,505,224,974.65
  少数股东权益1,349,575,542.231,384,069,761.531,370,165,705.831,168,803,615.25
  股东权益合计6,867,962,080.336,933,891,733.146,884,996,978.596,674,028,589.9
  负债和股东权益合计21,128,623,814.6121,452,010,858.121,391,903,386.9621,537,284,924.56
公告日期2026-08-222026-04-252026-04-182025-10-25
审计意见(境内)标准无保留意见
TOP↑